Followers | 149 |
Posts | 2303 |
Boards Moderated | 0 |
Alias Born | 01/24/2012 |

Sunday, February 17, 2019 5:44:37 PM
In this time and age its very very very simple. A person should learn about a company, see if it has a product that can appeal and be sold to the end consumer.
If yes, get in early...buy low and don't fall in love or get attached. Sell for a profit
I can give so many suggestions and methods to make money on the market, but one thing for sure don't short. Its a dangerous game.
IMHO and in what I truly believe is ACRX has a product that is going to meet an important need, local and international, at the hospitals and most importantly in the battlefield. When hospitals realize the savings and quick action they can treat a patient, its going to be their favorite Pain medication to provide quick pain relief to their patients.
Personally i am long in ACRX and will never sell all my shares as i know in 2 to 3 years this will be above and stable over $50+.
Cheers mate.
Recent TLPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:52:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:49:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:47:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2025 09:09:30 PM
- Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study • PR Newswire (US) • 01/14/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 09:31:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 11:05:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:22:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:20:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 05:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 09:30:26 PM
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors • PR Newswire (US) • 11/25/2024 12:27:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:15:14 PM
- Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/13/2024 09:05:00 PM
- Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 • PR Newswire (US) • 11/06/2024 09:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:25:36 PM
- Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit • PR Newswire (US) • 10/08/2024 08:54:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 09:29:07 PM
- Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 09/05/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:22:55 PM
- Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit • PR Newswire (US) • 08/19/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/14/2024 09:22:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:12:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:10:32 PM
- Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/14/2024 08:01:00 PM
VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM
ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM
VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM
Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM
VAYK Issues Clerical Correction to Feb 18 News Regarding Shareholder Premium • VAYK • Feb 26, 2025 10:32 AM